This website is intended for healthcare professionals only.
ADVANCING IN mPaCa - OPTIMIZING TREATMENTS FOR PATIENTS
Prof Hanneke Wilmink, MD PhD Medical Oncologist Amsterdam University Medical Center(UMC), the Netherlands
Prof Dr Thomas Seufferlein
Medical Director Clinic for Internal Medicine University Hospital Ulm, Germany
This webinar introduced ways in which mPaCa treatment could be optimized, discussing both precision medicine, which is still in its infancy and early treatment planning. An interactive clinical patient case is presented, with a focus on treatment planning.
Key points covered
This webinar highlights the ways in which mPaCa treatment can be optimized and improved. These include:
Precision medicine, with up to 25% of mPaCa patient harboring actionable molecular alterations.
Treatment planning, with the need to factor 2L from the start.
An interactive clinical patient case is also presented, with a focus on treatment planning.
Webinar Replay
Featured Speakers
Prof. Wilmink
Prof Hanneke Wilmink, MD PhD Medical Oncologist Amsterdam University Medical Center(UMC), the Netherlands
Prof. Seufferlein
Head of GI oncology – Curie Institute, France
Prof Seufferlein MD, PhD obtained his doctorate at the II. medical clinic of the Klinikum Rechts der Isar of the Technical University of Munich. From Berlin, he moved to London where, he worked at the Imperial Cancer Research Fund (now: Cancer Research UK) as a postdoc in the laboratory of Dr. E. Rozengurt for several years. After his postdoctoral period, he continued his clinical activities in Ulm at the Department of Internal Medicine I and obtained the specialist degree in Internal Medicine and the specialization in Gastroenterology.
